Iterum Therapeutics plc CEO Corey Fishman's 2019 pay falls 21% to $1.4M
Iterum Therapeutics plc reports 2019 executive compensation
By ExecPay News
Published: May 7, 2020
Iterum Therapeutics plc reported fiscal year 2019 executive compensation information on May 7, 2020.
In 2019, three executives at Iterum Therapeutics plc received on average a compensation package of $947K, a 19% decrease compared to previous year.
Average pay of disclosed executives at Iterum Therapeutics plc
Corey N. Fishman, Chief Executive Officer, received $1.4M in total, which decreased by 21% compared to 2018. 40% of Fishman's compensation, or $561K, was in option awards. Fishman also received $152K in non-equity incentive plan, $551K in salary, $123K in stock awards, as well as $4.9K in other compensation.
Michael W. Dunne, Chief Scientific Officer, received a compensation package of $883K, which decreased by 23% compared to previous year. 46% of the compensation package, or $403K, was in salary.
Judith M. Matthews, Chief Financial Officer, earned $565K in 2019, a 8% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on May 7, 2020.